Illumina Pursues a $20B Market
Apr 29, 2015, 00:00 AM
by
Michael Croft
Forbes | Illumina, one of the most important
companies in biomedicine, is still barely known to the public. But
scientists, diagnostics makers, physicians, and Wall Street look at
the company with a mix of fear and awe. Just as Intel became the
company that sparked so much of the computer revolution, Illumina
is driving the genomics revolution.
April 29, 2015 | Illumina, one of the most important companies in biomedicine, is still barely known to the public. But scientists, diagnostics makers, physicians, and Wall Street look at the company with a mix of fear and awe. Just as Intel became the company that sparked so much of the computer revolution, Illumina is driving the genomics revolution. Forbes


